当前位置：首页 SCI 期刊医学 Dermatology And Therapy(非官网)

Dermatology And TherapySCIE

国际简称：DERMATOLOGY THER 参考译名：皮肤科和治疗

中科院分区
3区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：2193-8210; E-ISSN：2190-9172; 是否OA：开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：Germany; 出版商：Springer Healthcare; 出版语言：English; 出版周期：12 issues per year; 出版年份：2011; 研究方向：Medicine-Dermatology

评价信息：: 影响因子：3.5; CiteScore指数：6; SJR指数：1.424; SNIP指数：1.328

发文数据：: Gold OA文章占比：98.75%; 研究类文章占比：75.94%; 年发文量：187; 自引率：0.0882...; 开源占比：0.992; 出版撤稿占比：0; 出版国人文章占比：0.04; OA被引用占比：1

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Dermatology And Therapy期刊介绍

Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols, and short communications. Dermatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an International and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. The journal appeals to a global audience and receives submissions from all over the world.

期刊简介Dermatology And Therapy期刊介绍

《Dermatology And Therapy》自2011出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间： 6 Weeks
医学
DERMATOLOGY
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Dermatology And Therapy Cite Score数据

CiteScore：6
SJR：1.424
SNIP：1.328

学科类别	分区	排名	百分位
大类：Medicine 小类：Dermatology	Q1	17 / 142	88%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Dermatology And Therapy 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	3区	DERMATOLOGY 皮肤病学	3区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Dermatology And Therapy JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：DERMATOLOGY	SCIE	Q1	20 / 94	79.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：DERMATOLOGY	SCIE	Q1	19 / 94	80.32%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA108
Italy41
Spain28
France27
GERMANY (FED REP GER)26
England22
CHINA MAINLAND18
Poland18
Belgium14
Canada12

本刊中国学者近年发表论文

1、Design of Effisayil (TM) 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
Author: Morita, Akimichi; Choon, Siew Eng; Bachelez, Herve; Anadkat, Milan J.; Marrakchi, Slaheddine; Zheng, Min; Tsai, Tsen-Fang; Turki, Hamida; Hua, Harry; Rajeswari, Sushmita; Thoma, Christian; Burden, A. David

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 347-359. DOI: 10.1007/s13555-022-00835-6
2、Effect of 30% Supramolecular Salicylic Acid Peel on Skin Microbiota and Inflammation in Patients with Moderate-to-Severe Acne Vulgaris
Author: Shao, Xinyi; Chen, Yangmei; Zhang, Lingzhao; Zhang, Yujie; Ariyawati, Asoka; Chen, Tingqiao; Chen, Jiayi; Liu, Lin; Pu, Yihuan; Li, Yuxin; Chen, Jin

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 155-168. DOI: 10.1007/s13555-022-00844-5
3、Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
Author: Yu, Chen; Wang, Gang; Burge, Russel T.; Ye, Erjia; Dou, Guanshen; Li, Jinnan; Harrison, Ryan W.; McLean, Robert R.; Kerti, Samantha J.; Bagel, Jerry

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 187-206. DOI: 10.1007/s13555-022-00843-6
4、Application of Comfort Therapy under eCASH Concept in Acute and Chronic Wound Treatment
Author: Shi, Shuting; Wei, Jiayu; Lyu, Guozhong; Zhong, Xiaohui; Zhu, Lihong; Yang, Minlie

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 299-314. DOI: 10.1007/s13555-022-00852-5
5、Effectiveness and Safety of Guselkumab for the Treatment of Psoriasis in Real-World Settings at 52 weeks: A Retrospective, Observational, Multicenter Study from China
Author: Yang, Jing; Hu, Kun; Li, Xingyu; Hu, Jingjin; Tan, Minjia; Zhang, Mi; Kuang, Yehong; Lv, Chengzhi; Chen, Junchen

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 2, pp. 477-485. DOI: 10.1007/s13555-022-00869-w
6、Efficacy, Safety and Pharmacokinetics of IL-17 Monoclonal Antibody Injection (AK111) in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blinded, Placebo-Controlled Phase Ib Multidose Escalation Clinical Study
Author: Jiang, Congjun; Zhou, Huan; Zhang, Wanlu; Xia, Yu; Li, Baiyong; Ni, Xiang; Wang, Guoqin; Zhang, Wenhui; Chen, Benchao; He, Zhimei; Zhang, Min; Chen, Rui; Jin, Hongzhong; Deng, Liehua

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 2, pp. 555-567. DOI: 10.1007/s13555-022-00880-1
7、An Intelligent Diagnostic Model for Melasma Based on Deep Learning and Multimode Image Input
Author: Liu, Lin; Liang, Chen; Xue, Yuzhou; Chen, Tingqiao; Chen, Yangmei; Lan, Yufan; Wen, Jiamei; Shao, Xinyi; Chen, Jin

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 2, pp. 569-579. DOI: 10.1007/s13555-022-00874-z
8、Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
Author: Chu, Chia-Yu; Yao, Tsung-Chieh; Shih, I. -Hsin; Yang, Chin-Yi; Chin, Chan Lee; Ibrahim, Sabeera Begum Binti Kader; Thevarajah, Suganthi; Fon, Leong Kin; Ho, Marco Hok-Kung; Mo, Chow Chung; Yu, Chow Pok; Loo, Steven King-Fan; Luger, Thomas

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 3, pp. 717-727. DOI: 10.1007/s13555-022-00886-9